Veteran private equity investor with multi-decade experience focused on growth and buyout transactions across healthcare, technology and industrials. Benjamin S. Smith has led deal sourcing, due diligence and portfolio company operations, emphasizing EBITDA expansion and strategic M&A. Known for fundraising with institutional limited partners and for board-level oversight, he combines operational leadership with capital markets fluency to drive exits via trade sales and IPOs. Regularly advises management teams on scaling, governance and value creation.
Veteran private equity investor with multi-decade experience focused on growth and buyout transactions across healthcare, technology and industrials. Benjamin S. Smith has led deal sourcing, due diligence and portfolio company operations, emphasizing EBITDA expansion and strategic M&A. Known for fundraising with institutional limited partners and for board-level oversight, he combines operational leadership with capital markets fluency to drive exits via trade sales and IPOs. Regularly advises management teams on scaling, governance and value creation.
Seasoned private equity investor focused on control and growth buyouts across healthcare, technology and industrials, deploying capital to drive EBITDA expansion via hands-on operational improvement and strategic M&A. Investment decisions prioritize durable competitive advantages, scalable business models and clear exit pathways via trade sale or IPO. Capital allocation is control-oriented with a mid-to-long term horizon, active board governance, disciplined underwriting and risk mitigation through operational de-risking and diversified sector exposure, supported by institutional LP relationships and capital markets fluency.
Seasoned private equity investor focused on control and growth buyouts across healthcare, technology and industrials, deploying capital to drive EBITDA expansion via hands-on operational improvement and strategic M&A. Investment decisions prioritize durable competitive advantages, scalable business models and clear exit pathways via trade sale or IPO. Capital allocation is control-oriented with a mid-to-long term horizon, active board governance, disciplined underwriting and risk mitigation through operational de-risking and diversified sector exposure, supported by institutional LP relationships and capital markets fluency.
| Trades 444 | Longs Won 277/444 62% | Profit Factor 2.32 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $116,294.32 |
| Average Win $45,796.04 | Best Trade (Jul 15) $895,162.08 | Sharpe Ratio -9.93 |
| Average Loss -$32,799.65 | Worst Trade (Jul 15) -$876,627.99 | Z-Score -1.2 (77.18%) |
| Commissions $0 | Avg. Trade Length 10m 3w 1d | Expectancy $16,234.15 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,861 | 3,475 | 3,089 | 2,703 | 2,317 | 1,931 | 1,544 | 1,158 | 772 | 386 |